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Abstract 
B-Myb (Mybl2) is a member of the Myb gene family of transcription factors involved in 
the control of cell growth, differentiation, and apoptosis. The effects of B-Myb on 
keratinocyte proliferation and differentiation have not yet been clarified. The present 
study was performed to examine the role of B-Myb in proliferation and differentiation 
of the spontaneously immortalized human skin keratinocyte cell line HaCaT and normal 
human keratinocytes (NHK) with formation of a stratified epidermoid structure in 
air–liquid interface 3-dimensional culture. B-Myb was expressed specifically in 
undifferentiated normal keratinocytes and downregulated during differentiation. The 
constitutive overexpression of B-Myb in HaCaT cells during air exposure-induced 
differentiation resulted in an undifferentiated phenotype, i.e., thickening of the stratified 
layers, suppression of differentiation marker expression, and retention of proliferative 
activity with activation of cell cycle regulatory proteins in the S and G2/M phases. In 
contrast, suppression of B-Myb caused their downregulation and constrained 
proliferation with retention of differentiation capacity. These findings suggested that 
B-Myb may play an important role in maintenance of the undifferentiated phenotype of 
keratinocytes in the basal epidermal layer.
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Introduction 
The epidermis is a self-renewing tissue that provides a useful system in which to study 
the processes involved in cell proliferation and differentiation. An elaborate and defined 
program of differentiation is involved in the structural and functional maturation of 
epidermal keratinocytes. Undifferentiated keratinocytes in the basal layer have high 
rates of proliferative activity, and these cells undergo cell cycle arrest and achieve 
differentiation as they move up to the suprabasal layers. Analyses of epidermal 
differentiation identified a set of genes that are transcribed only during certain stages of 
differentiation. Keratinocytes in the basal layer express keratin 5 (K5) and keratin 14 
(K14) (1). Upon maturation in the spinous layer, K5 and K14 are downregulated and the 
genes encoding keratin 1 (K1) and keratin 10 (K10) are induced (2) (3). As these cells 
differentiate into granular layer cells, they cease expression of K1 and K10 and show 
induction of late-differentiation products, such as filaggrin (4) (5), involucrin (6), and 
loricrin (7). 
B-Myb (Mybl2) is a member of the Myb gene family of transcription factors involved in 
the control of cell growth, differentiation, and apoptosis. The Myb gene family consists 
of three members: c-Myb, A-Myb, and B-Myb (8). B-Myb is ubiquitously expressed, 
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whereas c-Myb and A-Myb have restricted tissue-specific expression patterns (9). 
A-Myb is expressed primarily in B-cells, developing nerve cells, and reproductive 
tissues, while c-Myb is mainly expressed in hematopoietic precursors (10). The level of 
B-Myb protein is proportional to the degree of cell proliferation (11). B-Myb has been 
shown to be overexpressed in prostate cancer (12) and basal-like breast cancer (13), and 
it is involved in the poor prognosis of these diseases. Cyclin D1 quenches B-Myb 
transactivation by interfering with CBP/p300 until cyclin D1 destruction in late G1 
phase. From late G1 phase, B-Myb is phosphorylated and activated by cdk2 and cyclin 
A/E. B-Myb stimulates the transcription of genes that promote entry into the G2/M 
phases of the cell cycle (14) (11) (15). In terms of proliferation and differentiation, 
B-Myb is downregulated during colon epithelial cell maturation (16). However, the role 
of B-Myb in cell cycle progression is dependent on cell type (17). 
In the present study, I examined the role of B-Myb in differentiation of the 
spontaneously immortalized human skin keratinocyte cell line HaCaT and normal 
human keratinocytes (NHK) with formation of a stratified epidermoid structure in 
air–liquid interface 3-dimensional (3D) culture. 
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Material & Methods 
Plasmids 
The plasmid pAct-B-Myb carrying human B-Myb DNA was a kind gift from Dr. 
Shunsuke Ishii (Laboratory of Molecular Genetics, RIKEN Tsukuba Institute, Tsukuba, 
Japan). The pCMV expression vector pCMV-B-Myb was derived from pRC/CMV 
empty vector (Invitrogen Life Technologies, Carlsbad, USA) by subcloning the 
SacII/XbaI fragment from pAct-B-Myb. The construct was confirmed by enzymatic 
digestion and sequencing before use. 
 
Cell culture 
HaCaT cells were maintained in MCDB153 medium (Sigma Aldrich, St. Louis, USA) 
supplemented with 0.1 mM calcium chloride, 10 ng ml
–1
 epidermal growth factor (EGF) 
(Sigma Aldrich), 1% penicillin-streptomycin solution (Sigma Aldrich), and 5% dialyzed 
fetal bovine serum (Gibco-BRL, Paisley, UK) as described previously (18). Primary 
mouse keratinocyte cultures were prepared as described previously (19). Normal human 
keratinocytes (NHKs) (FC-0007, Lifeline cell technology, Frederick, USA) were 
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cultured in Dermalife K medium complete kit (Lifeline cell technology) in accordance 
with the manufacturer’s instructions. 3D cell culture was performed as described 
previously (20). 
 
DNA transfection 
HaCaT cells were transfected using the TransIT-LT1 Transfection Reagent (Mirus Bio, 
Madison, USA) in accordance with the manufacturer’s recommendations. DNA 
complex was prepared using 1 μg of plasmid, 3 μl of LT1, and Eagle’s minimal essential 
medium. Stable HaCaT clones transfected with pCMV-B-Myb and with empty pCMV 
vector alone were selected and maintained in the presence of 300 μg ml–1 of the 
aminoglycoside antibiotic G418 (Geneticin; Gibco-BRL). Single colonies were cloned 
from one HaCaT cell, and the cells were proliferated in 24-well plates or in dishes 10 
cm in diameter. 
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Immunoblotting 
Cells were solubilized using Sample Buffer Solution (Wako, Osaka, Japan). The 
whole-cell lysates were subjected to SDS-PAGE on Mini-PROTEAN TGX Precast Gels 
(Bio-Rad, Hercules, USA), and the proteins were transferred onto nitrocellulose 
membranes (GE Healthcare, Buckinghamshire, UK). The membranes were incubated 
overnight with primary antibodies against B-Myb (1 mg ml
–1
; Ab-577/581; 
Assaybiotech, San Francisco, USA), keratin 10 (0.2 mg ml
–1
; PRB-159P; Covance, 
Emeryville, USA), cyclin A (10 mg ml
–1
 RB-1548; Thermo Fisher Scientific, Newark, 
DE), cyclin B1 (05-373SP; Millipore, Billerica, USA), β-actin (0.2 mg ml–1; BioVision, 
Mountain View, USA) and CDK1 (CDC2; 0.2 mg ml
–1
; sc-54; Santa Cruz 
Biotechnology), followed by incubation for 60 min with horseradish peroxidase–labeled 
secondary antibodies against rabbit IgG (0.04 mg ml
–1
; Santa Cruz Biotechnology) and 
mouse IgG (0.4 mg ml
–1
; Santa Cruz Biotechnology). Antibody binding was visualized 
and enhanced with SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher 
Scientific) and Hyperfilm MP (GE Healthcare). 
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Measurement of thickness of epidermal layers 
Sections of 3D cultured cells stained with hematoxylin and eosin were examined. The 
thickness of the epidermal layer was measured using a digital microscope (AX80; 
Olympus, Tokyo, Japan). Ten points were selected at random and measured from the 
basal layer to the horny layer on vertical sections. 
 
Immunohistochemical staining 
Sections of 3D cultured cells were pretreated by autoclaving in 10 mM citrate buffer 
(pH 6.0) before immunostaining for antigen retrieval. Cells were immunostained for 
p-B-Myb (ab76009; Abcam, Cambridge, UK), loricrin (PRB-145P; Covance), 
involucrin (MS-126; Thermo Fisher Scientific), keratin 10 (ab76318; Abcam), and 
Ki-67 (ab833; Abcam). All of the following procedures were carried out in accordance 
with standard protocols using an En Vision kit (Dako) and sections were lightly 
counterstained with hematoxylin. 
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Quantitative real-time RT-PCR Analysis 
Total RNA was extracted from culture dishes 10 cm in diameter at 80% – 90% 
confluency using ISOGEN (Nippon Gene, Tokyo, Japan), and complementary DNA 
(cDNA) was synthesized using a Prime Script RT Reagent kit (Takara Bio, Shiga, 
Japan). An ABI PRISM 7500 Sequence Detection System (Applied Biosystems, Foster 
City, USA) was used for SYBR Green (Takara Bio)-based quantitative analysis. The 
quantity of mRNA was normalized relative to that of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). Quantification was performed in triplicate. The primers used 
were as follows: 
B-Myb (human) (forward primer: 5'-GTAACAGCCTCACGCCCAAGA; reverse 
primer: 5'-GTGTCCTGTTTGTTCCAGAAGTT), B-Myb (mouse) (forward primer: 
5'-GTGTGGCCCATAGCTGGTG; reverse primer: 5'-CACCCAGGCAAGGCTACTG), 
keratin 10 (mouse) (forward primer: 5'-CTGACAATGCCAACGTGCTG; reverse 
primer: 5'-GCAGGGTCACCTCATTCTCGTA), Cyclin A1 (human) (forward primer: 
5'-GAAATTGTGCCTTGCCTGAGTG; reverse primer: 
5'-TCTGATATGGAGGTGAAGTTCTG), CDK1 (human) (forward primer: 
5'-GTGGCCAGAAGTGGAATCTTTAC; reverse primer: 
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5'-CGTTTGGCTGGATCATAGATTAACA), CDK2 (human) (forward primer: 
5'-CATGGATGCCTCTGCTCTCAC; reverse primer: 
5'-GACCCGATGAGAATGGCAGAA), GAPDH (human) (forward primer: 
5'-GCACCGTCAAGGCTGAGAAC; reverse primer: 
5'-TGGTGAAGACGCCAGTGGA), GAPDH (mouse) (forward primer: 
5'-AAATGGTGAAGGTCGGTGTGAAC; reverse primer: 
5'-CAACAATCTCCACTTTGCCACTG). 
 
Silencing of B-Myb expression in HaCaT cells 
Lentiviral particles encoding shRNA targeting B-Myb mRNA were purchased from 
Santa Cruz Biotechnology (sc-43523-V). Lentiviral particles encoding a scrambled 
shRNA sequence (sc-108080) were also purchased from the same source for use as a 
control. HaCaT cells and NHKs were transduced with these lentiviral particles 
according to the manufacturer’s instructions, and the knockdown efficacy was assessed 
at the protein level by Western blotting. 
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Measurement of NHKs proliferation rate 
NHKs of each strain were seeded into six-well plates at a density of 5×10
4
 cells per well 
in the growth medium. The next day, the medium was replaced with fresh medium. The 
numbers of cells in triplicate wells were counted by trypsinization after 48 and 96 hours 
after seeding. 
 
Statistical analysis 
Data are expressed as means ± SD. Comparisons among groups were carried out using 
the paired Student’s t test. In all analyses, P < 0.05 was taken to indicate statistical 
significance. 
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Results 
B-Myb expression is downregulated during normal keratinocyte differentiation 
Normal neonatal murine keratinocytes were cultured in medium containing a low or 
high calcium concentration. Normal murine keratinocytes (NMKs) cultured under 
high-calcium conditions undergo a phenomenon known as the calcium switch, which 
involves cell cycle exit followed by terminal differentiation (19). The results of 
quantitative real-time PCR indicated significantly elevated B-Myb expression in 
undifferentiated keratinocytes cultured under low-calcium conditions (0.05 mM 
calcium) compared to differentiated keratinocytes cultured under high-calcium 
conditions (0.12 mM calcium) at the mRNA level (Figure 1a). In addition, the results of 
immunoblotting analyses indicated significantly elevation of B-Myb expression in 
undifferentiated keratinocytes compared to differentiated keratinocytes at the protein 
level (Figure 1b). Therefore, these findings indicated that B-Myb is expressed 
specifically in undifferentiated keratinocytes and downregulated during their 
differentiation. 
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Figure 1 
Expression of B-Myb in the normal keratinocytes.  
(a) Total RNAs extracted from neonatal murine keratinocytes (NMKs) cultured in 
medium containing low or high levels of calcium were subjected to quantitative 
real-time PCR. Relative expression of B-Myb and keratin 10 (K10) mRNAs in NMKs 
under low- and high-calcium conditions. B-Myb mRNA expression level was 6.3-fold 
higher under low-calcium conditions than under high-calcium conditions. The results 
indicated cell cycle-dependent transcriptional regulation of B-Myb. The expression 
levels were normalized relative to that of glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA. All values represent means ± SD from three independent 
experiments. **P < 0.01. (b) Immunoblotting of whole-cell extracts from NMKs 
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cultured under low- or high-calcium conditions. B-Myb protein expression became 
almost undetectable as NMKs underwent differentiation. 
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HaCaT cells overexpressing B-Myb formed an epidermoid epithelium with 
increased thickness in 3D culture 
The 3D cultures of control HaCaT cells (Figure 2b, left column) and those 
overexpressing B-Myb (Figure 2b, right column) grown for 4, 7, 10, and 14 days 
showed layers mimicking the epidermal structure. The mean thicknesses of the 
epithelial layers were measured after 4, 7, 10, and 14 days of culture (Figure 2c). The 
cultures of HaCaT-B-Myb cells became thicker than those of cultures of HaCaT-control 
cells on days 4, 7, 10, and 14. These observations indicated that B-Myb accelerates the 
cell cycle and cell proliferation. This was supported by the results of immunostaining 
for Ki-67 (Figure 2d). On days 4 and 7, cultures of HaCaT-B-Myb and HaCaT-control 
cells showed appropriately equivalent numbers of Ki-67-positive cells. On the other 
hand, more Ki-67-positive cells were observed in cultures of HaCaT-B-Myb cells than 
HaCaT-control cells on days 10 and 14. These findings suggested that the 
overexpression of B-Myb was responsible for cell proliferation, thus resulting in an 
increase in thickness of the epithelia. 
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Overexpression of B-Myb in HaCaT cells suppressed epithelial keratinization and 
maintained the cells in an undifferentiated condition under 3D conditions 
The effects of B-Myb on keratinocyte differentiation in 3D culture were analyzed by 
histological immunostaining of 3D cultures for several epithelial differentiation 
markers: i.e., loricrin as a marker of terminal differentiation, involucrin as a marker of 
late-stage differentiation, and K10 as a marker of early-stage differentiation. The levels 
of expression of the early-stage, late-stage and terminal differentiation markers K10, 
involucrin, and loricrin, respectively, were markedly decreased in 
B-Myb-overexpressing epithelia in comparison with the controls (Figure 2e). Positive 
immunoreactivity for the undifferentiated basal cell marker K14 was detected in all 
layers in both B-Myb-transfected and control epithelia. These findings indicated that 
overexpression of B-Myb in HaCaT cells functionally suppresses epithelial 
keratinization and maintains the cells in the undifferentiated state. 
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Figure 2 
Effects of B-Myb overexpression on the morphology of three-dimensional (3D) cell 
cultures. 
(a) Whole-cell lysates from HaCaT cells transfected with B-Myb expression vector or 
empty vector were analyzed with B-Myb protein expression by immunoblotting 
analysis. Control: control cultures. B-Myb: pCMV-B-Myb-treated cultures. (b) 
Hematoxylin and eosin (HE) staining of HaCaT 3D cell cultures. Control cultures, left 
column; pCMV-B-Myb-treated cultures, right column. Overexpression of B-Myb in 
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HaCaT cells increased the thickness of epithelial cell layers. (c) Thickness of 
epidermoid layers. All values represent means ± SD (n = 3). * P < 0.05 vs. control, ** P 
< 0.01 vs. control. (d) Immunostaining for Ki-67 in HaCaT 3D cell cultures. Control 
cultures, left column; pCMV-B-Myb-treated cultures, right column. Data are means ± 
SD (n = 3). *P < 0.05 vs. control. (e) Immunostaining for the differentiation markers 
K10, loricrin, and involucrin in HaCaT 3D cell cultures. Control cultures, left column; 
pCMV-B-Myb -treated cultures, right column. Bar = 50 μm. 
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ShRNA-mediated silencing of B-Myb in HaCaT cells inhibited epithelial 
thickening and decreased thickness in 3D culture 
The expression of B-Myb was suppressed by lentiviral vector-expressed short hairpin 
RNA (shRNA) treatment. Control HaCaT cells (Figure 3b, left column) and sh-B-Myb 
HaCaT cells (Figure 3b, right column) were grown in 3D culture for 4 – 14 days. The 
controls were transduced with scramble lentiviral vector. The mean thicknesses of the 
epithelial layers were measured after 4, 7, 10, and 14 days of culture (Figure 3c). The 
cultures of sh-B-Myb HaCaT cells were not as thick as those of the control HaCaT cells 
on days 4, 7, 10, and 14. These observations were inversely related to the 
overexpression of B-Myb indicating that B-Myb is required to some extent for the cell 
cycle and cell proliferation. This was also supported by the results of immunostaining 
for Ki-67 (Figure 3d). That is, fewer Ki-67-positive cells were observed on days 4, 7, 10, 
and 14 in cultures of sh-B-Myb HaCaT cells than control HaCaT cells. These findings 
suggest that the suppression of B-Myb expression abrogated cell proliferation and 
resulted in a decrease in thickness of the epithelia. The suppression of B-Myb resulted 
in a decrease in thickness of undifferentiated layers, which do not express differentiation 
markers, such as K10 and involucrin (Figure 3e). 
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Figure 3  
Effects of short hairpin RNA (shRNA)-mediated silencing of B-Myb expression on 
the morphology of three-dimensional (3D) cell cultures. 
(a) Whole-cell lysates from HaCaT cells treated with lentiviral particles expressing 
shRNA targeting the B-Myb mRNA or non-target control were analyzed with B-Myb 
protein expression by immunoblotting analysis. Control: control cultures. sh-B-Myb: 
shRNA-treated cultures. (b) Hematoxylin and eosin (HE) staining of HaCaT 3D cell 
cultures. Control cultures, left column; shRNA-treated cultures, right column. Silencing 
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of B-Myb expression in HaCaT cells inhibited growing thick. (c) Thickness of 
epidermoid layers. All values represent means ± SD (n=3). * p<0.05 vs. control. ** 
p<0.01 vs. control. (d) Immunostaining for Ki-67 staining of HaCaT 3D cell cultures. 
Control cultures, left column; shRNA-treated cultures, right column. Data are mean ± 
SD (n=3). **p<0.01 vs. controls. (e) Immunostaining for the differentiation markers; 
K10, loricrin, and involucrin staining of HaCaT 3D cell cultures. Control cultures, left 
column; shRNA-treated cultures, right column. Bar=50μm. 
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ShRNA-mediated silencing of B-Myb in NHKs inhibited epithelial thickning and 
decreased thickness in 3D culture 
The 3D cultures of the control NHKs (Figure 4a, left column) and sh-B-Myb NHKs 
(Figure 4a, right column) were grown for 2-7 days. The mean thickness of the epithelial 
layers was measured after 2, 4, and 7 days of culture (Figure 4b). The cultures of 
shB-Myb NHKs became less thickened than the cultures of the control NHKs on days 2, 
4, and 7 days. On days 2, 4 and 7, less Ki-67-positive cells were observed in the cultures 
of sh-B-Myb NHKs than that of the control NHKs (Figure 4c). The suppression of 
B-Myb resulted in decrease in thickness of undifferentiated layers which do not express 
the differentiation markers such as K10 and involucrin (Figure 5a).  
 
ShRNA-mediated silencing of B-Myb in NHKs inhibited epithelial thickning and 
decreased thickness in 2D condition. 
We also examined the effect of the change in B-Myb expression level on keratinocyte 
proliferation ability in 2D condition. Suppression of B-Myb resulted in a decrease in 
proliferation rate (Figure 5b).  
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Figure 4  
Effects of short hairpin RNA (shRNA)-mediated silencing of B-Myb expression on 
the morphology of normal human keratinocytes (NHKs). 
(a) Hematoxylin and eosin (HE) staining of NHKs 3D cell cultures. Control cultures, 
left column; shRNA-treated cultures, right column. Silencing of B-Myb expression in 
NHKs inhibited growing thick. (b) Thickness of epidermoid layers. All values represent 
means ± SD (n=3). * p<0.05 vs. control. ** p<0.01 vs. control. (c) Immunostaining for 
Ki-67 staining of NHKs 3D cell cultures. Control cultures, left column; shRNA-treated 
cultures, right column. Data are mean ± SD (n=3). **p<0.01 vs. control. 
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Figure 5 
Effects of silencing of B-Myb expression about differentiation of normal human 
keratinocytes (NHKs) and proliferation rate. 
(a) Immunostaining for the differentiation markers; K14, K10, loricrin, and involucrin 
staining of NHKs 3D cell cultures. Control cultures, left column; shRNA-treated 
cultures, right column. Bar=50μm. (b) Proliferation rate was assayed by cell counting 
under 2D condition. B-Myb silenced NHKs showed a decreased proliferation rate 
compared with control. **p<0.01 vs. control. 
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Overexpression of B-Myb in HaCaT cells has a positive effect on S and G2/M cell 
cycle regulatory factor expression 
 We analyzed the effects of B-Myb on expression of endogenous cell cycle and 
proliferation regulatory factors. Immunoblotting analysis and quantitative real-time 
PCR were performed to monitor the expression of cyclin A, CDK2, and CDK1, which 
are activators of cell proliferation and S phase and G2/M phase progression (Figure 6a 
and 6b). Overexpression of B-Myb in HaCaT cells resulted in upregulation of cyclin A, 
CDK2, and CDK1 expression at the mRNA level and overexpression of cyclin A and 
CDK1 on immunoblotting analysis. Also expression of phosphorylated B-Myb is 
upregulated on immunobloting analysis. 
 
shRNA-mediated silencing of B-Myb has a negative effect on G2/M cell cycle 
regulatory factor expression at the mRNA level 
 We also analyzed the effects of B-Myb silencing on expression of endogenous cell 
cycle and proliferation regulatory factors. Immunoblotting analysis and quantitative 
real-time PCR were performed to monitor the expression of cyclin A, CDK2, and CDK1 
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(Figure 6c and 6d). Silencing of B-Myb in HaCaT cells resulted in downregulation of 
cyclin A, CDK2, and CDK1 at the mRNA level and decreased expression on 
immunoblotting analysis. Similar to HaCaT cells, silencing of B-Myb in NHKs induced 
downregulation of cyclin A, CDK2 and CDK1 in mRNA level (Figure 7). 
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Figure 6  
Effects of B-Myb overexpression and silencing on expression of cell cycle markers 
in HaCaT cells. 
(a) Representative results of immunoblotting analysis of whole-cell lysates from HaCaT 
cells with specific antibodies for B-Myb, phosphorylated B-Myb, cyclin A, and CDK1. 
Control: Cells transfected with empty vector pAct. B-Myb: Cells transfected with 
27 
B-Myb expression vector pAct-B-Myb. (b) Total RNAs extracted from HaCaT cells 
were subjected to quantitative real-time PCR. Relative expression levels of B-Myb, 
cyclin A1, CDK2, and CDK1 mRNA. The expression levels were normalized relative to 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA expression. * P < 0.05 vs. 
control, ** P < 0.01 vs. control. (c) Representative results of immunoblotting analysis 
of whole-cell lysates from HaCaT cells with specific antibodies for B-Myb, 
phosphorylated B-Myb, cyclin A, and CDK1. sh-B-Myb: Cells transfected with shRNA 
targeting B-Myb mRNA. Control: Cells transfected with non-target shRNA. (d) Total 
RNAs extracted from HaCaT cells were subjected to quantitative real-time PCR. 
Relative expression levels of B-Myb, cyclin A1, CDK2, and CDK1 mRNA. The 
expression levels were normalized relative to GAPDH mRNA expression. ** P < 0.01 
vs. control. 
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Figure 7 
Effects of silencing of B-Myb expression on expression of cell cycle markers in 
NHKs. 
Total RNAs extracted from NHKs were subjected to quantitative real-time PCR. 
Relative expression levels of B-Myb, cyclin A1, CDK2 and CDK1 mRNA. The 
expression levels were normalized relative to GAPDH mRNA expression. * p<0.05 vs. 
control, ** p<0.01 vs. control. 
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Discussion 
Undifferentiated keratinocytes at the basal layer have high rates of proliferative activity, 
and these cells undergo cell cycle arrest and differentiation as they move up to the 
suprabasal layers. We showed that B-Myb, which is expressed specifically in 
undifferentiated keratinocytes, is downregulated during differentiation induced by the 
calcium switch. These observations support the reciprocity between proliferative 
capacity and differentiation. 
The 3D cell culture of HaCaT cells used in the present study, in which cell monolayers 
are allowed to differentiate and undergo stratification in response to air exposure, is a 
suitable model in which to study the in vitro differentiation of keratinocytes (18). Using 
the 3D cell culture system, we showed that excess and constitutive expression of B-Myb 
in HaCaT cells resulted in arrest of cell differentiation, and that they retained the 
undifferentiated phenotypes of keratinocytes, including increased cell proliferation and 
suppression of differentiation markers, such as keratin 10, involucrin, and loricrin. 
Conversely, 3D cultures of sh-B-Myb HaCaT cells and sh-B-Myb NHKs showed 
decreased proliferation. These results suggest that B-Myb plays important roles in 
maintenance of keratinocytes in the undifferentiated state. The majority of previous 
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reports were consistent with the hypothesis that B-Myb activation is associated with 
cellular proliferation, as its expression can overcome G1 arrest in glioblastoma cells 
(21). Moreover, its expression appears to inhibit differentiation, as B-Myb was reported 
to be downregulated during colon epithelial cell maturation (16). 
The B-Myb overexpression and suppression in 3D cell culture of HaCaT cells and 
NHKs indicated that B-Myb plays an important role in controlling cell proliferation. In 
addition, cell proliferation induced by overexpression of B-Myb suppressed epithelial 
keratinization and maintained the cells in the undifferentiated state. Experiments 
involving culture under 3D conditions indicated that excess B-Myb protein enhanced 
proliferation by upregulation of S and G2/M cell cycle accelerators, and the lack of 
B-Myb protein appeared to accelerate the differentiation of keratinocytes. Cyclin D1 
quenches B-Myb transactivation until late G1 phase. From late G1 phase, B-Myb is 
phosphorylated and activated by cdk2 and cyclin A/E. In concert with E2F1-3, B-Myb 
regulates the expression of genes required for the G2/M phase of the cell cycle, such as 
cdc2, cyclin A2, and cyclin B1 (11). However, the role of B-Myb in cell cycle 
progression is dependent on cell type (17). The effects of B-Myb on keratinocytes are 
not yet clear. Overexpression of B-Myb in HaCaT cells resulted in upregulation of S 
phase proteins, such as cyclin A and CDK2, and G2/M phase proteins, such as cyclin A 
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and CDK1, at the mRNA and protein levels. Silencing of B-Myb in HaCaT cells and 
NHKs resulted in downregulation of cyclin A, CDK2, and CDK1 at the mRNA level. 
These results indicated that B-Myb promotes transcription of cyclin A, CDK2, and 
CDK1.  
In conclusion, the findings of the present study suggested that B-Myb plays an 
important role in the suppression of keratinocyte differentiation and maintenance of the 
undifferentiated proliferative phenotype by modulating the expression levels of other 
cell cycle regulatory proteins, especially those expressed in the S and G2/M phases of 
the cell cycle. 
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